NCT07803315Recruiting
Hyperspectral Imaging in Robot-Assisted Partial Nephrectomy
Perfusion Mapping and Tissue Characterization Using Hyperspectral Imaging in Robot-Assisted Partial Nephrectomy
Source: ClinicalTrials.gov · Last updated 3 Sept 2026
Brief summary (registry, in English)
The goal of this prospective observational study is to learn about the use of a novel imaging technique called hyperspectral imaging in adult participants who are having surgery for removing a tumor from their kidney. Hyperspectral imaging works by shining light on a structure (in this case, the kidney tissue with the tumor) and capturing how it reflects hundreds of very narrow color bands, including ones the human eye can't see. These patterns depend on the composition of the tissue and for example how well blood is flowing through the tissue. By studying these patterns, the investigators want to understand if this technique can be helpful for the surgery where only the part of the kidney with the tumor is removed. The main questions it aims to answer are: * Can hyperspectral imaging show the areas of blood flow in the kidney during surgery? * Is there a connection between the detected patterns of light and the type of kidney tumor? The imaging will happen during the already planned surgery and the participant does not need to undergo any additional tests.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 60 (estimated)
- First submitted
- 14 Aug 2025
- Start date
- 1 Sept 2026
- Primary completion date
- Aug 2028
- Lead sponsor
- University of Leipzig
- Diseases
- Kidney cancer
- NCT number
- NCT07803315
What you commit to
- Study type: Observational
- Planned participants: 60
- From 1 Sept 2026 to the primary completion date, Aug 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- patients with a previous surgery on the affected kidney
- current immunosuppression (e.g., organ transplantation, leukemia)
Other illness
- previous malignancy with ongoing or planned nephrotoxic chemotherapy
Other
- patients with a fully intrarenal/endophytic tumor without an exophytic component
- pregnancy, lactation, or women who wish to have children
- inability to give informed consent
Who the study is looking for
- Patients with a kidney tumor ≤7cm
- planned robot-assisted partial nephrectomy
- age ≥ 18 years
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Hospital Leipzig Coordinator of this site? Confirm its status | Leipzig | Germany | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.